Free Trial
ASX:COH

Cochlear (COH) Stock Price, News & Analysis

Cochlear logo

About Cochlear Stock (ASX:COH)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
201,277 shs
Average Volume
N/A
Market Capitalization
A$19.88 billion
P/E Ratio
55.90
Dividend Yield
1.35%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive COH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter.

COH Stock News Headlines

Banks aren’t ready for this altcoin—are you?
I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.
See More Headlines

COH Stock Analysis - Frequently Asked Questions

Cochlear Limited (ASX:COH) released its earnings results on Tuesday, February, 19th. The company reported $2.15 earnings per share for the quarter, missing analysts' consensus estimates of $2.19 by $0.04. Cochlear had a net margin of 15.80% and a trailing twelve-month return on equity of 19.70%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cochlear investors own include CSL (CSL), ResMed (RMD), NIB (NHF), Accent Group (AX1), Corporate Travel Management (CTD), Mineral Resources (MIN) and Technology One (TNE).

Company Calendar

Last Earnings
2/19/2019
Ex-Dividend for 4/13 Dividend
3/19/2025
Record date for 4/13 Dividend
4/13/2025
Dividend Payable
4/13/2025
Today
7/05/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
ASX:COH
CIK
N/A
Fax
N/A
Employees
4,996
Year Founded
N/A

Profitability

Trailing P/E Ratio
55.90
Forward P/E Ratio
N/A
P/E Growth
3.87
Net Income
A$356.80 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$2.24 billion
Price / Cash Flow
123.45
Book Value
A$28.10 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$19.88 billion
Optionable
Not Optionable
Beta
0.47
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (ASX:COH) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners